Best Foundayo (Orforglipron) Providers in 2026 — Ranked & Reviewed
Eli Lilly won approval for Foundayo (orforglipron) on April 1, 2026, making it the first oral GLP-1 receptor agonist to hold FDA approval in chronic weight management. Commercial dispensing began on April 6, 2026. The provider list is still short and growing quickly. We track each US telehealth platform, and each pharmacy, confirmed as a Foundayo channel, verifying the pricing tiers on each provider's own website. A commercially insured patient using the Lilly Savings Card pays $25/month; cash-pay runs $149-$299/month. This page is updated weekly as further providers come online.
Lowest verified price: $149/mo10 providers compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
10 foundayo (orforglipron) providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
a priced catalog across microdose, standard, oral drop and tablet routes
From /mo$269Flat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatideOrforglipron oral orforglipron alongside the injectables
From /mo$149Coverage36 statesMedicationsSemaglutideTirzepatideOrforglipron- Nationwide Coverage
knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
From /mo$149Coverage50 statesMedicationsOrforglipron
Show 5 moreShow fewer
- Best Budget
oral orforglipron alongside the injectables
From /mo$25Scales with doseCoverage50 statesMedicationsOrforglipron oral orforglipron alongside the injectables
From /mo$25Coverage50 statesMedicationsOrforglipronoral orforglipron alongside the injectables
From /mo$149Scales with doseCoverage48 statesMedicationsOrforglipronTirzepatidetirzepatide from $299/month
From /mo$149CoverageCheck intakeMedicationsTirzepatideSemaglutideOrforglipronoral orforglipron alongside the injectables
From /mo$149CoverageCheck intakeMedicationsSemaglutideTirzepatideOrforglipron
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
| ★ Editor's Pick BH Bayan Healtha priced catalog across microdose, standard, oral drop and tablet routes | $269 Flat pricing | SemaglutideTirzepatideOrforglipron | Check intake | Visit → | |
 oral orforglipron alongside the injectables | $149 | SemaglutideTirzepatideOrforglipron | 36 states | Visit → | |
Nationwide Coverage knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC | $149 | Orforglipron | 50 states | Visit → | |
Best Budget oral orforglipron alongside the injectables | $25 Scales by dose | Orforglipron | 50 states | Visit → | |
 oral orforglipron alongside the injectables | $25 | Orforglipron | 50 states | Visit → | |
 oral orforglipron alongside the injectables | $149 Scales by dose | OrforglipronTirzepatide | 48 states | Visit → | |
 tirzepatide from $299/month | $149 | TirzepatideSemaglutideOrforglipron | Check intake | Visit → | |
 oral orforglipron alongside the injectables | $149 | SemaglutideTirzepatideOrforglipron | Check intake | Visit → |
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Detailed Reviews
Bayan Health
Best for: a priced catalog across microdose, standard, oral drop and tablet routes
Bayan Health publishes a full shop-style catalog rather than a plan card: microdose semaglutide and tirzepatide with B6 at $99 and $119, standard doses at $129 and $149, oral drops at $99 and $119, and Orforglipron Oral Tablets at $269. It states no memberships, no dose-based price increases and no hidden fees, and says its medications come from US 503A pharmacy partners without naming them. Its Terms name no operating entity.
Score Breakdown
Pros
- ✓Semaglutide costs $99 a month, 46% below the $185 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $119 a month, 52% below the $250 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓We found no FDA warning letters issued to Bayan Health
Cons
- ✗Confirm it serves your state before you start the intake
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
PreventiveMD
Best for: oral orforglipron alongside the injectables
All-in figures start at $83/mo for compounded semaglutide and $97/mo for compounded tirzepatide. Foundayo, Zepbound and Wegovy come as brands under a membership arrangement. Requests reach a US-licensed provider inside 24 hours, and once approved the drug is sent to your door with care continuing through a portal online. Peptide therapy shares the platform with the GLP-1 side, all physician-guided.
Score Breakdown
Pros
- ✓Semaglutide costs $149 a month, 85% below the $997 median for brand-name semaglutide across the sellers we compare
- ✓Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- ✓Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication and clinician visits
- ✓We found no FDA warning letters issued to PreventiveMD
Cons
- ✗Serves only 36 states, so check that yours is one of them
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Ro
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Score breakdown, pros and cons
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Score Breakdown
Pros
- ✓Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes clinician visits, lab work and coaching
- ✓Serves all 50 states
- ✓Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Ro
Cons
- ✗Not included in the monthly price: medication
LillyDirect Foundayo
Best for: oral orforglipron alongside the injectables
Score breakdown, pros and cons
Any licensed prescriber can write it, but LillyDirect will not ship without a valid US prescription. Eli Lilly runs this channel itself, direct-pay, and what it sells is Foundayo (orforglipron): for weight loss, the first oral GLP-1 pill. Commercially insured patients holding the Lilly Savings Card pay $25/month. Paying cash costs $149-$299/month, depending on labeled dose.
Score Breakdown
Pros
- ✓Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to LillyDirect Foundayo
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
Amazon One Medical
Best for: oral orforglipron alongside the injectables
Score breakdown, pros and cons
Amazon runs its GLP-1 business through a single unified channel here. Prescribing sits with One Medical clinicians and covers three FDA-approved drugs, Foundayo, Zepbound, and Wegovy, with nothing compounded on the list. Fulfillment is Amazon Pharmacy: same-day delivery in roughly 3,000 US cities, or pickup kiosks at select One Medical locations. Membership beforehand is not a prerequisite, and cash pay and insurance are both accepted. Foundayo launched at $25/month for patients with insurance and the Lilly Savings Card, $149/month paying cash.
Score Breakdown
Pros
- ✓Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes clinician visits and shipping
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to Amazon One Medical
- ✓Baseline bloodwork is required before a prescription
Cons
- ✗Not included in the monthly price: medication, lab work
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
Buying Foundayo (orforglipron): what to verify
Foundayo is the first oral GLP-1 pill the FDA has approved for weight loss, and only a small dispensing channel exists so far. It is one Lilly product. The entries here separate on access, on price, and on whether a seller is a real channel for it at all.
What to check
- A verified channel for the real product. Specific pharmacies dispense this drug. A seller either sits inside that channel or it does not, and the distinction is checkable. Compounded orforglipron is not a legitimate product, and no listing offering one belongs in this category.
- Whether the Lilly savings card gets applied. For commercially insured patients who qualify, the manufacturer savings card cuts the monthly cost substantially. Applying it is something a seller does or omits, and an omission usually goes unmentioned.
- An intake a clinician actually reads. This is a prescription drug, and the review behind it is meant to be a medical one. Approval issued in seconds, with nobody reachable afterward, describes a storefront rather than a practice.
Red flags
- Pharmacy unnamed and no LegitScript listing. Two disclosures are checkable on any compounded-GLP-1 seller: the 503A or 503B pharmacy filling the vial, and a LegitScript certification. When a site publishes neither, nothing about the contents of that vial can be confirmed from outside.
- Instant approval with no clinician you can reach. A prescriber is supposed to read the intake and stay available once dose questions start. Approval issued automatically, with nobody reachable afterward, means the medical layer was removed rather than streamlined.
- The advertised number is a first month. Headline figures here are usually qualified somewhere. Common forms are an opening rate that steps up with each dose increase, and a membership fee billed separately from the drug itself. Either one can double what leaves your account in month two.
- B12, MIC, or HCG sold for weight loss. Trial evidence for weight loss sits with the GLP-1 injections and nowhere else on this aisle. A clinic that lists lipotropic, B12, or HCG shots under weight loss is selling past the record, whatever its own site says.
Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Orforglipron · Drugs and brands
- Foundayo · Drugs and brands
- Wegovy · Drugs and brands
- Zepbound · Drugs and brands
- GLP-1 receptor · Mechanism
- STEP-1 · Major trials
- Compounded GLP-1 · Pharmacy and drug forms
Sources & methodology — as of September 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.